Often promoted as less-potent alternatives to cannabis, Delta-8 THC products have seen a rapid growth in the U.S. marketplace and are showing up in commercial tobacco retail stores across the nation in the form of e-cigarettes, combustible products, beverages, and snacks. The manufacturing of Delta-8 THC and similar hemp-derived cannabis products is unregulated and can involve the use of harmful chemicals in uncontrolled settings. In addition, these products can have psychoactive and intoxicating effects and can pose risks to young people, pets, and others.
Join the Public Health Law Center with our special guest, Dr. Gillian Schauer, Executive Director of the Cannabis Regulators Association (CANNRA), as we unpack all things Delta-8 THC (and beyond) for this hour long webinar. We will discuss the mechanics and chemistry behind Delta- 8 THC and similar novel cannabinoids, the legal landscape, and efforts to regulate these products to protect vulnerable communities and public health.
Dr. Gillian Schauer, Executive Director of the Cannabis Regulators Association (CANNRA)
Rachel Callanan, Public Health Law Center
Manire Vaughn, Public Health Law Center